Keywords: Malignant neoplasms; Oncogenes; Viruses; HPV; Lifetime risk;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Cancer risk assessment; Linear non-threshold dose-response; Oncogenes; Threshold dose-response; Carcinogen mechanism;
Keywords: Endoplasmic reticulum; Mitochondria; Mitochondria associated membranes (MAMs; Calcium; ROS; ER-mitochondria contact sites; Ca2+ transfer; Cell death; Apoptosis; Oncogenes; Tumor suppressors;
Keywords: Epigenetics; Cancer; Oncogenes; Tumor suppressor genes; Therapy;
Keywords: Cancer; Extracellular vesicles; Exosomes; Oncogenes; Oncosomes; Vesiculome; Ras; EGFR; Horizontal transformation; Brain tumours; Colorectal carcinoma;
Keywords: MECs; mammary epithelial cells; Beta1-integrin; Mammary epithelial cells; Proliferation; Oncogenes;
Keywords: protein kinases; thyroid carcinoma; vascular endothelial growth factor; oncogenes; RECIST;
Keywords: myrAKT; myristoylated AKT1; AKT/RAS; myrAKT and NRAS; HCC; hepatocellular carcinoma; PBS; phosphate-buffered saline; H&E; hematoxylin and eosin; I.P.; intraperitoneal; dpi; days post-injection; mAB; monoclonal antibody; Oncogenes; MYC; AKT; RAS; Tumor; In
Keywords: genetics; genetic syndromes; inherited cancer risk; melanoma; oncogenes; skin cancer; tumor suppressor; ACD; adrenocortical dysplasia homologue; BAP1; BRCA1-associated protein-1 (ubiquitin carboxy-terminal hydrolase); CDKN2A; cyclin-dependent kinase inhib
Keywords: Leukemia, myelogenous, chronic, BCR-ABL positive; Philadelphia chromosome; Chromosome breakpoints; Oncogenes; Brazil
Keywords: Non-small cell lung cancer; African American; mutations; Oncogenes; Tumor suppressors;
Keywords: Oncogenes; Tumoral reprogramming; Stem cells; Cancer stem cell; Mouse model
Keywords: Bayesian nonparametric variable selection; DNA microarrays; Oncogenes; Support vector machine; Cancer prognosis;
Keywords: Glioblastoma; Extracellular vesicles; Exosomes; Glioma stem cells; Oncogenes; Cancer;
Keywords: Langerhans cell histiocytosis; Neurodegeneration; Oncogenes; BRAF; Chemotherapy;
Keywords: Focal CNA; Chromosomal aberrations; Driver genes; Oncogenes; Tumor suppressor genes;
Keywords: Chemical synthetic lethality; Genetic synthetic lethality; Oncogenes; Tumor suppressor genes; RNAi; Cancer therapy;
Keywords: Brain neoplasms; immunocytochemistry; methylation; morphology; oncogenes; tumour suppressor genes;
Translocation-generated ITK-FER and ITK-SYK fusions induce STAT3 phosphorylation and CD69 expression
Keywords: Chimeric tyrosine kinases; Fusion genes; ITK; SYK; FER; Oncogenes;
Hallmarks of cancer: The CRISPR generation
Keywords: Cancer; Clustered regularly interspaced short palindromic repeats; CRISPR-Cas systems; Genetic engineering; Gene editing; Epigenetics; Epigenetic editing; Oncogenes; Tumour-suppressor genes;
Genome-wide analysis of H3K36me3 and its regulations to cancer-related genes expression in human cell lines
Keywords: H3K36me3; Histone modifications; Oncogenes; Tumor-suppressor genes;
Is DNA damage indispensable for stress-induced senescence?
Keywords: Chromatin; DNA damage response; Oncogenes; Stress; Tumour supressors;
Presence of a consensus DNA motif at nearby DNA sequence of the mutation susceptible CG nucleotides
Keywords: TS; tumor suppressor; DNMT1; DNA methyltransferase 1; NTDs; nucleotides; AAs; amino acids; RMSD; root mean square deviation; MD; molecular dynamics; HB; hydrogen bond; PWM; position weight matrix; Mutation; Epigenetics; CpG islands; Tumor suppressors; Onc
Targeting G-quadruplex DNA structures in the telomere and oncogene promoter regions by benzimidazoleâcarbazole ligands
Keywords: Oncogenes; G-quadruplex DNA; Benzimidazoleâcarbazole conjugates; Thiazole orange; Fluorescence intercalator displacement; Polymerase stop assay; Transcriptional regulation;
Regulatory players of DNA damage repair mechanisms: Role in Cancer Chemoresistance
Keywords: Chemoresistance; DNA repair; Oncogenes; Hypoxia; Bystander signaling and cancer stem cells;
DNA methylation analysis of cancer-related genes from cell-free DNA of patients with cancer
Keywords: DNA methylation; Tumor suppressor genes; Oncogenes; Epigenetics; Cell-free DNA;
Prognostic Effect of Complex Karyotype, Monosomal Karyotype, and Chromosome 17Â Abnormalities in B-Cell Acute Lymphoblastic Leukemia
Keywords: Cytogenetic risk analysis; p53; Oncogenes; Multivariate analysis; Risk groups;
Cáncer hereditario y consejo genético oncológico
Keywords: Cáncer hereditario; Oncogenes; Genes supresores de tumores; Mutaciones somáticas; Mutaciones germinales; Consejo genético; Hereditary cancer; Oncogenes; Tumor suppressor genes; Somatic mutations; Germinal mutations; Genetic counseling;
DNA methylation data for identification of epigenetic targets of resveratrol in triple negative breast cancer cells
Keywords: Breast cancer; Resveratrol; DNA methylation; Oncogenes; Tumor suppressor genes; Genome-wide methylome;
The emerging role of long non-coding RNA in gallbladder cancer pathogenesis
Keywords: Long non-coding RNA; LncRNAs; Gallbladder cancer; Oncogenes; Tumor suppressors; Biomarkers; Diagnostic markers; Prognostic markers;
Analysis of distribution of DNA methylation in kidney-renal-clear-cell-carcinoma specific genes using entropy
Keywords: DNA methylation; Entropy; Cancer; Tumor suppressor genes; Oncogenes;
The amplification of c-erb-B2 in cancer-free surgical margins is a predictor of poor outcome in oral squamous cell carcinoma
Keywords: oral cancer; oncogenes; H-ras; c-Myc; c-erb-B2; mutation; amplification
Oncogene mutation profiling reveals poor prognosis associated with FGFR1/3 mutation in liposarcoma
Keywords: Liposarcomas; Mutations; Oncogenes; MassARRAY technology; FGFR1/3; Prognosis;
DNA replication and cancer: From dysfunctional replication origin activities to therapeutic opportunities
Keywords: Replicative stress; Oncogenes; Genetic instability; Cancer therapy; Fork restart
Exploring miRNA based approaches in cancer diagnostics and therapeutics
Keywords: miRNA; microRNA; TRBP; Transactivating Response RNA-Binding Protein; RISC; RNA induced silencing complex; UTR; untranslated region; DDX; DEAD box protein; TS; tumor suppressor; OG; oncogene; TGF β; Transforming Growth Factor β; RT-PCR; Real Time-polymer
Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer
Keywords: Breast cancer; Oncogenes; Epigenomics; Estrogen receptor; Estrogen-independence;
The use of Gene Ontology terms and KEGG pathways for analysis and prediction of oncogenes
Keywords: Oncogenes; Gene Ontology; KEGG pathway; Minimum redundancy maximum relevance; Incremental feature selection; Random forest;
ER functions of oncogenes and tumor suppressors: Modulators of intracellular Ca2Â + signaling
Keywords: a.a.; amino acid; ATP; adenosine triphosphate; BH domain; Bcl-2-homology domain; BI-1; Bax inhibitor-1; BIRD-2; Bcl-2/IP3R disruptor-2; BRCA1; breast and ovarian cancer susceptibility gene 1; [Ca2Â +]cyt; cytosolic Ca2Â + concentration; CLL; chronic lymph
DNA damage checkpoint recovery and cancer development
Keywords: DNA damage; Cell cycle checkpoints; Carcinogenesis; Neoplasms; Oncogenes;
A Murine Model of K-RAS and β-Catenin Induced Renal Tumors Expresses High Levels of E2F1 and Resembles Human Wilms Tumor
Keywords: kidney; Wilms tumor; oncogenes; beta catenin; models; animalCTNNB1, stabilizing/activating mutations of β-catenin; EXALT, Expression AnaLysis Tool; GEO, Gene Expression Omnibus; IHC, immunohistochemistry; IPA, Ingenuity® Pathway Analysis; NCBI, National C
Targeting strategies on miRNA-21 and PDCD4 for glioblastoma
Keywords: GBM; glioblastoma multiforme; miRNAs; microRNAs; PDCD4; programmed cell death 4; EMT; epithelial-mesenchymal transition; JNK; Jun N-terminal protein kinase; PTEN; phosphatase and tensin homolog; PI3K/AKT; phosphatidylinositol-3 kinase/Akt; MAPK/ERK; mit
PIM kinase (and Akt) biology and signaling in tumors
Keywords: PIM kinases; Akt; Oncogenes; Cancer; Therapeutic resistance; AML; acute myeloid leukemia; AMPK; AMP activated protein kinase; CXCR-4; C-X-C chemokine receptor type 4; EGFR; epidermal growth factor receptor; EBV; Epstein-Barr virus; FLT3; FMS-like ty
Analiza amplifikowanych regionów chromosomów zawierajÄ
cych potencjalne onkogeny w pÅaskonabÅonkowym nowotworze krtani
Keywords: amplifikacje; onkogeny; pÅaskonabÅonkowy rak krtani; gen wiodÄ
cy; Amplifications; Oncogenes; Laryngeal squamous cell carcinoma; Driver gene;
Regulation of Nrf2—an update
Keywords: Nrf2, NF-E2 related factor 2; INrf2, inhibitor of Nrf2, also known as Keap1; ARE, antioxidant-response element; ROS, reactive oxygen speciesNrf2; INrf2 (Keap1); Antioxidants; Vitamins; Phytochemicals; ROS; Signaling; Regulation; Chemoprotection; Oncogenes
BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: Implications for melanoma staging and adjuvant therapy
Keywords: Melanoma; Molecular diagnostic techniques; Oncogenes; Proto-oncogene proteins B-raf;
Differential expression of secretoglobins in normal ovary and in ovarian carcinoma - Overexpression of mammaglobin-1 is linked to tumor progression
Keywords: Secretoglobins; Oncogenes; Expression regulation; Immunohistochemistry; Tumor growth; Quantitative real time PCR; Ovarian cancer;
The role of EVI1 in myeloid malignancies
Keywords: Leukemogenesis; Oncogenes; EVI1; Myeloid leukemia; Apoptosis; Differentiation;
PDGF receptor signaling networks in normal and cancer cells
Keywords: PDGFRA; PDGFRB; Receptor tyrosine kinase; Myeloproliferative neoplasms; Oncogenes
Context-dependent signal integration by the GLI code: The oncogenic load, pathways, modifiers and implications for cancer therapy
Keywords: GLI transcription factors; Hedgehog-GLI signaling; Cancer; Development; Signal transduction; Signaling integration; Oncogenes; Stem cells;
Oncogene alterations in endometrial carcinosarcomasâ
Keywords: Endometrial carcinosarcomas; Oncogenes; Predictive markers;